Morning Market Losers By: Benzinga via Benzinga March 31, 2014 at 09:50 AM EDT Prana Biotechnology (NASDAQ: PRAN) shares tumbled 70.79% to $2.88 on failed Phase 2 Alzheimer's trial results. Clean Diesel ... Read More >> Related Stocks: General Motors Ocean Bio Chem Inc